An open-label, multicentre, phase 2 study of trastuzumab deruxtecan in patients with HER2-expressing solid tumours: DESTINY-PanTumor02 Part 2 Meeting Abstract
| Authors: | Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Anoka, C.; Jung, L.; Puvvada, S.; Simões, J.; Meric-Bernstam, F. |
| Abstract Title: | An open-label, multicentre, phase 2 study of trastuzumab deruxtecan in patients with HER2-expressing solid tumours: DESTINY-PanTumor02 Part 2 |
| Meeting Title: | ESGO 2025 Congress |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 35 |
| Issue: | 2 Suppl. 1 |
| Meeting Dates: | 2025 Feb 20-23 |
| Meeting Location: | Rome, Italy |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2025-02-01 |
| Start Page: | 101598 |
| Language: | English |
| ACCESSION: | WOS:001546403600118 |
| DOI: | 10.1016/j.ijgc.2024.101598 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 389 -- Source: Wos |
